VC firm / fund
TCGX
TCGX has backed 3 tracked startups across Health, totalling $1.3B raised. Public investment activity below — sourced from Datapile’s funding database.
3
Tracked deals
$1.3B
Total raised
2026
Active since
$330M
Median round
Deals over time
What TCGX invests in
Round-size distribution
Total round sizes (not this investor’s specific check) across their tracked deals.
Frequent co-investors
ARCH Venture Partners1Bain Capital Life Sciences1Droia1EQT Life Sciences1Kalehua Capital1Life Sciences at Goldman Sachs Alternatives1Medicxi1Omega Funds1Perceptive Advisors1
Recent investments
| Company | Sector | Round | When |
|---|---|---|---|
| Vaderis | Health | $152M · Series B | Aug 2026 |
| Alkeus Pharmaceuticals | Health | $800M | Aug 2026 |
| Ollin Biosciences | Health | $330M · Series B | Jun 2026 |
Reach TCGX and 326,000+ more investors
Datapile tracks verified contacts, focus areas, and full deal history for investors worldwide.
Aggregated from public funding announcements in Datapile’s database. Investor names are matched from round data and may include name variants.